期刊
JOURNAL OF CELL SCIENCE
卷 125, 期 12, 页码 2815-2824出版社
COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.095000
关键词
ATF2; Transcription; DNA damage; Mitochondria; Melanoma; Skin cancer; JNK; p38 MAPK; PKC
类别
资金
- National Cancer Institute (NCI) [CA099961, CA117927, CA051995, T32-CA121949]
- ACS, Illinois Division [117090-PF-09-112-01-GMC]
An increasing number of transcription factors have been shown to elicit oncogenic and tumor suppressor activities, depending on the tissue and cell context. Activating transcription factor 2 (ATF2; also known as cAMP-dependent transcription factor ATF-2) has oncogenic activities in melanoma and tumor suppressor activities in non-malignant skin tumors and breast cancer. Recent work has shown that the opposing functions of ATF2 are associated with its subcellular localization. In the nucleus, ATF2 contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. ATF2 can also translocate to the cytosol, primarily following exposure to severe genotoxic stress, where it impairs mitochondrial membrane potential and promotes mitochondrial-based cell death. Notably, phosphorylation of ATF2 by the epsilon isoform of protein kinase C (PKC epsilon) is the master switch that controls its subcellular localization and function. Here, we summarize our current understanding of the regulation and function of ATF2 in both subcellular compartments. This mechanism of control of a non-genetically modified transcription factor represents a novel paradigm for 'oncogene addiction'.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据